ArticleInternational journal of molecular sciences2025

Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer.

Riya Khetan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.